4.7 Review

Bacterial Therapy of Cancer: A Way to the Dustbin of History or to the Medicine of the Future?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Recent advances in bacterial therapeutics based on sense and response

Zhuo Feng et al.

Summary: Intelligent drug delivery using bacteria as carriers has become a promising strategy for cancer therapies. By implanting condition-responsive elements or gene circuits into bacteria, drugs can be synthesized or released in a controlled manner, providing better targeting ability and copability with the complex delivery environment of the body. This review highlights the development of bacterial-based drug delivery carriers and discusses the challenges and prospects in clinical research.

ACTA PHARMACEUTICA SINICA B (2023)

Review Pharmacology & Pharmacy

Bacteria-based bioactive materials for cancer imaging and therapy

Ying Chen et al.

Summary: This review summarizes different types of bacteria-based bioactive materials and their construction strategies, and describes the advantages and property-function relationship of bacteria-based bioactive materials. Representative research in cancer imaging and therapy using bacteria-based bioactive materials is illustrated, and the limitations and challenges in cancer research are discussed.

ADVANCED DRUG DELIVERY REVIEWS (2023)

Review Oncology

Bugs as drugs: neglected but a promising future therapeutic strategy in cancer

Mithoor Divyashree et al.

Summary: Microbe-based cancer treatment uses tumor-specific infectious microbes to address difficult-to-treat cancers. These microbes can be self-regenerating therapeutics, and scientific research has shown that bacteria can be effective cancer prophylactic and therapeutic agents, as well as ideal carriers for targeted cancer therapy. Advanced molecular engineering techniques have improved the efficacy and reduced adverse effects of bacterial therapy.

FUTURE ONCOLOGY (2022)

Review Oncology

Bacterial-Based Methods for Cancer Treatment: What We Know and Where We Are

Foad Rommasi

Summary: Cancer, a severe disease caused by the abnormal growth of cells, poses challenges to health and medicine. Traditional cancer treatments like chemotherapy, surgery, and radiotherapy have drawbacks such as side effects and tumor cell resistance. Bacteria, with their potential for non-pathogenicity through genetic manipulation and virulence factors, are being explored as viable options for cancer therapy, despite challenges such as cytotoxic effects and incomplete cancer cell lysis.

ONCOLOGY AND THERAPY (2022)

Review Pharmacology & Pharmacy

Bacterial cancer therapy: A turning point for new paradigms

Vijayakumar Mayakrishnan et al.

Summary: Cancer treatments have improved significantly, but there is still room for improvement. In recent years, bacteria-based cancer therapy has gained attention for its unique properties, as bacteria can control tumor growth and improve prognosis.

DRUG DISCOVERY TODAY (2022)

Review Dentistry, Oral Surgery & Medicine

Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma

Richard J. Lamont et al.

Summary: Oral and esophageal squamous cell carcinomas have a distinct microbiome composition compared to precancerous and healthy tissues. Porphyromonas gingivalis, a periodontal pathogen, is associated with the cancerous state and poor prognosis. In vitro and in vivo studies have shown that P. gingivalis may promote tumor development through various mechanisms. The microbial community context also plays a role in oncogenicity, with some bacteria having protumorigenic or antagonistic effects. Metatranscriptomic data suggests that functional properties of tumor-associated communities are more relevant to cancer development than compositional properties. The consistent association of P. gingivalis with oral and orodigestive carcinoma could have diagnostic potential for early detection.

PERIODONTOLOGY 2000 (2022)

Review Oncology

Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives

Zheng Pang et al.

Summary: Drug resistance, toxicity, and lack of selectivity are major challenges in conventional cancer therapies. Utilizing bacteria as a strategy for cancer treatment, particularly Pseudomonas aeruginosa, shows promising results with high specificity and efficacy.

FRONTIERS IN ONCOLOGY (2022)

Article Microbiology

Can Mycobacterium tuberculosis infection lead to cancer? Call for a paradigm shift in understanding TB and cancer

Asrar A. Malik et al.

Summary: Bacterial infections, including Mycobacterium tuberculosis, have been associated with cancer development. However, more research is needed to confirm the carcinogenic properties of M. tb. Accurate diagnosis and treatment of tuberculosis and lung cancer are crucial for saving lives.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2022)

Article Oncology

Tumor Colonization and Therapy by Escherichia coli Nissle 1917 Strain in Syngeneic Tumor-Bearing Mice Is Strongly Affected by the Gut Microbiome

Ivaylo Gentschev et al.

Summary: The gut microbiome plays an important role in cancer therapy, and the Escherichia coli Nissle 1917 strain shows promise as a candidate for cancer treatment. Temporal depletion of the gut microbiome with antibiotics significantly enhances tumor colonization by EcN, leading to reduced tumor growth and improved survival. Depletion of the gut microbiome results in lower infiltration of cytotoxic and helper T cells in tumors treated with PBS compared to antibiotic-untreated mice or EcN-treated mice.

CANCERS (2022)

Review Oncology

Recent Advances in Bacteria-Based Cancer Treatment

Xianyuan Wei et al.

Summary: Bacteria play a significant role in cancer treatment and prevention, particularly in bacteria-based cancer immunotherapy. Compared to traditional cancer treatments, bacteria have versatile capabilities for suppressing cancer due to their preferential accumulation and proliferation within tumors. Genetically engineered bacteria and bacteria-based nanoparticles have shown promising results in efficient antitumor treatments. The design of bacteria with detoxification and specificity is crucial for the efficacy of bacteria-based cancer therapeutics.

CANCERS (2022)

Review Biotechnology & Applied Microbiology

New technologies in developing recombinant-attenuated bacteria for cancer therapy

Kang Liang et al.

Summary: Cancer treatment remains a global challenge, with traditional methods showing limitations and the need for new targeted therapies. Research on using bacteria for cancer therapy is widespread, with Salmonella being considered a promising agent or vehicle.

BIOTECHNOLOGY AND BIOENGINEERING (2021)

Review Oncology

Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors

Xu Feng et al.

Summary: The use of Clostridium novyi-NT in combating solid tumors has shown important potential by inducing oncolysis and immune responses through targeting the hypoxic and necrotic areas of tumors, providing a new approach to overcome the limitations of conventional cancer therapy.

ONCOLOGY LETTERS (2021)

Article Immunology

Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy

Kajal H. Gupta et al.

Summary: Cancer currently ranks as the sixth leading cause of death globally, with immunotherapy showing significant advancements in combating cancer. The use of bacteria and bacterial products as cancer therapy has promising potential to address ongoing challenges in cancer treatment.

VACCINES (2021)

Review Biochemistry & Molecular Biology

Dual Nature of Relationship between Mycobacteria and Cancer

Marek Fol et al.

Summary: Recent studies suggest that chronic inflammation related to mycobacteria may be a possible mechanism of cancer pathogenesis. Different types of mycobacterial infections, such as Mycobacterium tuberculosis, non-tuberculous Mycobacterium avium complex, and Mycobacterium ulcerans, have been associated with increased risks of lung cancer and skin carcinogenesis. The relationship between chronic mycobacterial infections and tumor development is thought to involve various host effector mechanisms at different stages of oncogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

Salmonella enterica subsp. enterica host-pathogen interactions and their implications in gallbladder cancer

Abdul Arif Khan et al.

Summary: The study found that Salmonella interacts with multiple human proteins involved in gallbladder carcinoma, with MAPK and RAC1 being the most important based on node degree value among all identified interactors. Functional over-representation analysis reveals that Salmonella can induce adenocarcinoma, which constitutes 85% of gallbladder cancer.

MICROBIAL PATHOGENESIS (2021)

Article Oncology

Simple and effective bacterial-based intratumoral cancer immunotherapy

Christina S. E. Carroll et al.

Summary: Intratumoral injection of a slow-release emulsion of killed mycobacteria shows significant antitumor effects in some animal models and is safe for use in human cancer patients. The treatment is simple and inexpensive, with potential for further trials in human cancer patients. This novel cancer immunotherapy is applicable to a wide range of solid tumors and suitable for patients in developing countries.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Biotechnology & Applied Microbiology

Engineering a probiotic strain of Escherichia coli to induce the regression of colorectal cancer through production of 5-aminolevulinic acid

Junhao Chen et al.

Summary: Engineered Escherichia coli Nissle 1917 successfully produced 5-aminolevulinic acid (5-ALA) and demonstrated its anticancer effects in colorectal cancer cells. This novel combination therapy showed significant efficacy in a mouse model and was non-toxic to normal tissues.

MICROBIAL BIOTECHNOLOGY (2021)

Review Oncology

Tweak to Treat: Reprograming Bacteria for Cancer Treatment

Brendan Fu-Long Sieow et al.

Summary: Recent advances in cancer biology, microbiology, and bioengineering have led to the development of engineered live biotherapeutics for targeted cancer therapy. Engineered bacteria, including tumor-targeting and probiotics, can deliver anticancer agents to the tumor microenvironment. Combination therapies involving engineered bacteria and traditional anticancer treatments show promise in addressing intratumor heterogeneity. Exciting prospects lie ahead for the clinical translation of engineered bacteria in cancer prevention and treatment.

TRENDS IN CANCER (2021)

Review Oncology

Molecular Mechanism ofHelicobacter pylori-Induced Gastric Cancer

Majid Alipour

Summary: This study aimed to investigate the role of Helicobacter pylori in the development of gastric cancer. It was found that H. pylori infection is a known risk factor for gastric cancer, and its virulence factors can trigger cell proliferation through activating cell signaling pathways, leading to cancer.

JOURNAL OF GASTROINTESTINAL CANCER (2021)

Review Pharmacology & Pharmacy

Antimicrobial peptides as novel therapeutics for non-small cell lung cancer

Nitesh K. Kunda

DRUG DISCOVERY TODAY (2020)

Review Pharmacology & Pharmacy

Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumours

Siamak Alizadeh et al.

JOURNAL OF DRUG TARGETING (2020)

Article Public, Environmental & Occupational Health

Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

Catherine de Martel et al.

LANCET GLOBAL HEALTH (2020)

Editorial Material Multidisciplinary Sciences

Probing the tumor micro(b)environment

Chloe E. Atreya et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

The human tumor microbiome is composed of tumor type-specific intracellular bacteria

Deborah Nejman et al.

SCIENCE (2020)

Review Virology

The long-standing history ofCorynebacterium parvum, immunity, and viruses

Beniamino Palmieri et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Review Medicine, Research & Experimental

Bacteria and cancer: Different sides of the same coin

Ghazaleh Laliani et al.

LIFE SCIENCES (2020)

Editorial Material Oncology

Cancer-Type-Specific Bacteria: Freeloaders or Partners?

K. Leigh Greathouse et al.

CANCER CELL (2020)

Article Biochemistry & Molecular Biology

Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics

Piyush Baindara et al.

BIOCHIMIE (2020)

Review Oncology

Bacteria-derived minicells for cancer therapy

Md Kaisar Ali et al.

CANCER LETTERS (2020)

Review Biochemistry & Molecular Biology

Microbe-Driven Genotoxicity in Gastrointestinal Carcinogenesis

Kimberly Hartl et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment

Shruti S. Sawant et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Chemistry, Multidisciplinary

Bacteria and bacterial derivatives as drug carriers for cancer therapy

Zhenping Cao et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Article Biochemical Research Methods

Engineering E. coli for Magnetic Control and the Spatial Localization of Functions

Mary Aubry et al.

ACS SYNTHETIC BIOLOGY (2020)

Review Immunology

The Oral Microbiome and Cancer

Muhammad Irfan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

The Intestinal Microbiota and Colorectal Cancer

Yiwen Cheng et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Multidisciplinary Sciences

Engineering microrobots for targeted cancer therapies from a medical perspective

Christine K. Schmidt et al.

NATURE COMMUNICATIONS (2020)

Review Cell Biology

Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives

Abdolmajid Ghasemian et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Microbiology

Development of bacteria as diagnostics and therapeutics by genetic engineering

Daejin Lim et al.

JOURNAL OF MICROBIOLOGY (2019)

Review Microbiology

Targeted Diphtheria Toxin-Based Therapy: A Review Article

Fatemeh Shafiee et al.

FRONTIERS IN MICROBIOLOGY (2019)

Review Biochemistry & Molecular Biology

Bacteria-cancer interactions: bacteria-based cancer therapy

Mai Thi-Quynh Duong et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2019)

Review Cell Biology

Fusobacterium nucleatum and colorectal cancer: A mechanistic overview

Nasser Hashemi Goradel et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Microbiology

Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity

Zachary T. Morrow et al.

CURRENT CLINICAL MICROBIOLOGY REPORTS (2019)

News Item Biochemical Research Methods

PART I: FIGHTING CANCER WITH DEADLY BACTERIAA

Kristie Nybo

BIOTECHNIQUES (2018)

Review Microbiology

Engineering bacteria for diagnostic and therapeutic applications

David T. Riglar et al.

NATURE REVIEWS MICROBIOLOGY (2018)

Review Urology & Nephrology

Mechanisms of BCG immunotherapy and its outlook for bladder cancer

Caroline Pettenati et al.

NATURE REVIEWS UROLOGY (2018)

Article Microbiology

Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions

M. Gabriela Kramer et al.

FRONTIERS IN MICROBIOLOGY (2018)

Review Oncology

The role of bacteria in cancer therapy - enemies in the past, but allies at present

Shiyu Song et al.

INFECTIOUS AGENTS AND CANCER (2018)

Review Pharmacology & Pharmacy

Anticancer Activity of Bacterial Proteins and Peptides

Tomasz M. Karpinski et al.

PHARMACEUTICS (2018)

Review Oncology

Fusobacterium nucleatum and colorectal cancer: A review

Fu-Mei Shang et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)

Article Oncology

White paper on microbial anti-cancer therapy and prevention

Neil S. Forbes et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

Review Oncology

Tumour-targeting bacteria engineered to fight cancer

Shibin Zhou et al.

NATURE REVIEWS CANCER (2018)

Review Oncology

The potential roles of bacteria to improve radiation treatment outcome

E. Kouhsari et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2018)

Review Biochemistry & Molecular Biology

Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer

Enea Gino Di Domenico et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Biochemistry & Molecular Biology

Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer

Ines Marmol et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Biotechnology & Applied Microbiology

Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome

Sebastian Felgner et al.

MICROBIAL BIOTECHNOLOGY (2017)

Article Oncology

The Role of the Microbiome in Cancer Development and Therapy

Aadra P. Bhatt et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Article Hematology

Bacteria associated with marginal zone lymphomas

Maurilio Ponzoni et al.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2017)

Review Biochemistry & Molecular Biology

Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challenges

Shreeram C. Nallar et al.

CYTOKINE (2017)

Review Environmental Sciences

Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis

Martyn T. Smith et al.

ENVIRONMENTAL HEALTH PERSPECTIVES (2016)

Review Pharmacology & Pharmacy

Bioengineered and biohybrid bacteria-based systems for drug delivery

Zeinab Hosseinidoust et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Article Nanoscience & Nanotechnology

Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions

Ouajdi Felfoul et al.

NATURE NANOTECHNOLOGY (2016)

Review Biochemistry & Molecular Biology

Clostridium novyi-NT in cancer therapy

Verena Staedtke et al.

GENES & DISEASES (2016)

Review Microbiology

Pseudomonas Exotoxin A: optimized by evolution for effective killing

Marta Michalska et al.

FRONTIERS IN MICROBIOLOGY (2015)

Review Pharmacology & Pharmacy

Bacteriocins as Potential Anticancer Agents

Sumanpreet Kaur et al.

FRONTIERS IN PHARMACOLOGY (2015)

Review Obstetrics & Gynecology

Chlamydia trachomatis infection: implications for HPV status and cervical cancer

Jani Silva et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)

Article Cell Biology

Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses

Nicholas J. Roberts et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Biotechnology & Applied Microbiology

Effects of biosurfactants on the viability and proliferation of human breast cancer cells

Cristina Duarte et al.

AMB EXPRESS (2014)

Article Oncology

Effect of Botulinum Toxin A on Proliferation and Apoptosis in the T47D Breast Cancer Cell Line

Cindy Bandala et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)

Article Biotechnology & Applied Microbiology

Engineering of Bacteria for the Visualization of Targeted Delivery of a Cytolytic Anticancer Agent

Sheng-Nan Jiang et al.

MOLECULAR THERAPY (2013)

Article Multidisciplinary Sciences

New paradigm for tumor theranostic methodology using bacteria-based microrobot

Sung Jun Park et al.

SCIENTIFIC REPORTS (2013)

Review Oncology

Bacteria and tumours: causative agents or opportunistic inhabitants?

Joanne Cummins et al.

INFECTIOUS AGENTS AND CANCER (2013)

Review Biotechnology & Applied Microbiology

Microbial biosurfactants: challenges and opportunities for future exploitation

Roger Marchant et al.

TRENDS IN BIOTECHNOLOGY (2012)

Review Toxicology

Clostridial Spores for Cancer Therapy: Targeting Solid Tumour Microenvironment

Brittany Umer et al.

JOURNAL OF TOXICOLOGY (2012)

Article Biotechnology & Applied Microbiology

Antitumor therapeutic effects of a genetically engineered Salmonella typhimurium harboring TNF-α in mice

Won Suck Yoon et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)

Review Microbiology

Role of Bacteria in Oncogenesis

Alicia H. Chang et al.

CLINICAL MICROBIOLOGY REVIEWS (2010)

Article Biotechnology & Applied Microbiology

A Novel Listeria monocytogenes-Based DNA Delivery System for Cancer Gene Therapy

Jan Peter van Pijkeren et al.

HUMAN GENE THERAPY (2010)

Article Multidisciplinary Sciences

Sensitivity of Cancer Cells to Truncated Diphtheria Toxin

Yi Zhang et al.

PLOS ONE (2010)

Review Oncology

Engineering the perfect (bacterial) cancer therapy

Neil S. Forbes

NATURE REVIEWS CANCER (2010)

Review Cell Biology

Bacteria in cancer therapy: a novel experimental strategy

S. Patyar et al.

JOURNAL OF BIOMEDICAL SCIENCE (2010)

Review Microbiology

Molecular control of bacterial death and lysis

Kelly C. Rice et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)

Review Biochemistry & Molecular Biology

Use of bacteria in anti-cancer therapies

RM Ryan et al.

BIOESSAYS (2006)

Article Toxicology

Pharmacologic and toxicologic evaluation of C-novyi-NT spores

LA Diaz et al.

TOXICOLOGICAL SCIENCES (2005)

Review Immunology

The three Es of cancer immunoediting

GP Dunn et al.

ANNUAL REVIEW OF IMMUNOLOGY (2004)

Article Medicine, Research & Experimental

Is this the historical 'cancer germ'?

M Wainwright et al.

MEDICAL HYPOTHESES (2003)